Qilu Inner Mongolia- Hulunbuir
Qilu Pharmaceutical （Inner Mongolia）Co., Ltd. Hulunbuir Branch, established in 2018, is the tenth manufacturing base of Qilu Pharmaceutical Group. Equipped with world-class manufacturing facilities and strong production capabilities, the company has established advanced green biomanufacturing facilities and currently operates one of the world's largest fermentation manufacturing bases for crop protection products.
The company is committed to technological innovation and has established a Pharmaceutical Research Institute dedicated to research in molecular biology, high-throughput strain screening and breeding, automated pilot-scale fermentation, and analytical testing. One of the company's major products, Spinosad, is characterized by high efficacy, broad-spectrum activity, biodegradability, and low toxicity to humans and other mammals. It is widely used in both cash-crop production and grain storage, helping reduce agricultural non-point source pollution while improving application safety. Spinosad and its second-generation derivative, Spinetoram, representing a significant domestic breakthrough and helping overcome the long-standing technological dominance of overseas manufacturers.
Leveraging the strengths and resources of Qilu Pharmaceutical Group, the company will continue to uphold its guiding principles of New Vision, New Thinking, New Starting Point, and New Heights. With a continued focus on green crop protection, it will further strengthen its R&D capabilities, advance long-term strategic development, and contribute to safer and more sustainable agricultural production—from farm to table.
Message Online
Please provide your relevant information and requirements. We will contact you within 1–2 business days. Thank you for your trust and support!
WeChat Official Account